Factor | Tenhagen2020 (40001)

No DOI

Production type

Turkey | Carcass

12

Description

Conventional vs organic, sampled in 2018 across Germany (# of samples in each region distributed according to the human population distribution). European organic production (Council Regulation (EC) No. 834/2007): AMU restricted to necessary cases, strict

Resistance Outcomes

Resistance Microbe Outcome
Ciprofloxacin
/
Campylobacter coli
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 19 22
Conventional 18 22
Erythromycin
/
Campylobacter coli
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 1 22
Conventional 3 22
Gentamicin
/
Campylobacter coli
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 0 22
Conventional 0 22
Nalidixic Acid
/
Campylobacter coli
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 19 22
Conventional 18 22
Streptomycin
/
Campylobacter coli
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 1 22
Conventional 4 22
Tetracycline
/
Campylobacter coli
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 15 22
Conventional 18 22
Ciprofloxacin
/
Campylobacter jejuni
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 24 51
Conventional 54 70
Erythromycin
/
Campylobacter jejuni
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 0 51
Conventional 0 70
Gentamicin
/
Campylobacter jejuni
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 0 51
Conventional 0 70
Nalidixic Acid
/
Campylobacter jejuni
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 23 51
Conventional 48 70
Streptomycin
/
Campylobacter jejuni
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 2 51
Conventional 2 70
Tetracycline
/
Campylobacter jejuni
See: Table 3 AMR+ (n) AMR- (n) Total (n)
Organic 9 51
Conventional 38 70